Company
Headquarters: Bangkok, Thailand
CEO: Dr. Ungoon Chantanavanich
฿3.33 Billion
THB as of July 1, 2024
US$90.6 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Ladprao General Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. It operates in two segments, Hospital, and Scientific Laboratory Testing & Research. The company operates Ladprao General Hospital, a private hospital with a capacity of approximately 200 in-patient beds and with approximately 500 physicians in various fields. Its hospital provides services in the areas of internal medicine, pediatrics, women's health, ophthalmology, otolaryngology, general surgery, orthopedic surgery, cardiology and neurology, skin and beauty, dentistry and hemodialysis, etc. The company also offers scientific analytical and diagnostic, and research services for medical, agricultural, food and drug industries; inspection and certification of quality systems; agricultural plant protection product efficiency assessment services; testing and analysis services for pesticide residues and hazardous substances; and hospital management and consulting services, as well as provides health mobile checkup and nurse services in factories and agencies. Ladprao General Hospital Public Company Limited was founded in 1990 and is based in Bangkok, Thailand.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Ladprao General Hospital Public Company Ltd has the following listings and related stock indices.
Stock: SET: LPH wb_incandescent
Stock: SET: LPH.R wb_incandescent